Indivumed Services, a Crown Bioscience Company, is a global contract research organization (CRO) that offers an industry-leading oncology biobank and a range of service platforms to advance oncology and immuno-oncology drug discovery and development.

Holding a unique biobank of clinical specimens, unrivalled in quality and associated clinical history, which currently totals almost one million patient samples, the company partners with extensive clinical network of more than 60 entities in the United States, Europe, and Asia providing direct and controlled access to relevant surgical biospecimen and blood samples.

Further known for their enhanced immunohistochemistry and spatial transcriptomics, Indivumed Services’ platforms complement a range of established Crown Bioscience capabilities supporting biomarker discovery.

Indivumed Services is headquartered in Hamburg, Germany, with a US-based subsidiary in Frederick, Maryland, USA, and employs approximately 120 people across these sites. Find out more: www.indivumedservices.com

Indivumed offers a wide range of products to support your research and development in personalized medicine, biomarker validation, drug discovery, and companion diagnostics in the field of oncology.

Indivumed offers biospecimens products, collected across all cancer types using our ISO-certified standardized protocol to ensure the highest quality product for every need:
• Multi-omics grade samples: Human biospecimens e.g. FFPE, fresh frozen, matched normal tissue, plasma, PBMCs
in combination with comprehensive clinical/medical data, controlled ischemia-time
• Standard grade samples: Qualified External Biospecimens
• Longitudinal cell-free plasma collection from oncology patients to study cDNA/ctDNA
• Clinical Data Sets
• Prospective collections on demand

We are able to facilitate the development of personalized medicines to meet all your oncology laboratory needs with the following services:
• Immunohistochemistry and fluorescent multiplex IHC (assay development, validation and prevalence analysis for
preclinical and clinical studies)
• Digital pathology department in-house
• Spatial Transcriptomics with 10x Genomics technology
• Drug profiling on cancer tissue slices
• Isolation and characterization of tumor infiltrating lymphocytes
• Mutation- and other genomics analysis
• Proteomics
• Other Customized Services